NCT07884903
Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks
StatusNot Yet Recruiting
PhaseNot specified
SponsorShanxi Bethune Hospital
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Incidence of Type 2 Diabetes Mellitus
Timeframe: 3 years
Incidence of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Timeframe: 3 years
Incidence of Hypertension
Timeframe: 3 years
Incidence of Atherosclerotic Cardiovascular Disease (ASCVD)
Timeframe: 3 years
Secondary (7)
Incidence of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
Incidence of Polycystic Ovary Syndrome (PCOS)
Incidence of Osteoarticular Disease
Incidence of Hyperuricemia
Incidence of Dyslipidemia
Show 2 moreShow less
Incidence of Microalbuminuria
Progression of Prediabetes to Diabetes
Arms and interventions
Overweight
Adults with BMI 23.0-27.4 kg/m². Target enrollment: 7,785 participants.
Mild Obesity
Adults with BMI 27.5-32.4 kg/m². Target enrollment: 7,785 participants.
Moderate Obesity
Adults with BMI 32.5-37.4 kg/m². Target enrollment: 7,785 participants.
Severe Obesity
Adults with BMI ≥37.5 kg/m². Target enrollment: 2,544 participants.
Other: No intervention; observational assessment only
Sites
1 site in 1 country
- Department of Endocrinology, Shanxi Bethune HospitalTaiyuan, Shanxi, China